KCNJ4: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 27: | Line 27: | ||
[[Category:Genes on human chromosome 11]] | [[Category:Genes on human chromosome 11]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 16:08, 17 March 2025
KCNJ4 also known as Potassium Inwardly-Rectifying Channel, Subfamily J, Member 4 is a protein that in humans is encoded by the KCNJ4 gene. It is a member of the potassium channel family of proteins, which are integral membrane proteins that establish the resting membrane potential, shape action potentials, and regulate the overall excitability of neurons.
Function[edit]
The KCNJ4 protein is part of the potassium channel, inwardly rectifying subfamily J (Kir). These channels are responsible for regulating potassium flow into cells, a process that is critical for maintaining the normal function of the heart and nervous system. The KCNJ4 channel is predominantly expressed in the brain and heart, where it plays a key role in controlling the electrical activity of these organs.
Structure[edit]
The KCNJ4 protein is composed of two identical subunits, each of which has two transmembrane domains and a pore region. The pore region is responsible for potassium selectivity and conductance, while the transmembrane domains are involved in gating and modulation of the channel.
Clinical significance[edit]
Mutations in the KCNJ4 gene have been associated with certain types of cardiac arrhythmia, including atrial fibrillation and long QT syndrome. These conditions can lead to life-threatening irregular heart rhythms. Research is ongoing to develop drugs that can modulate the activity of KCNJ4 and other potassium channels as a treatment for these and other diseases.
See also[edit]
References[edit]
<references />
External links[edit]
- KCNJ4 at the National Center for Biotechnology Information
